Myriad Genetics sell JPMorgan Chase & Co.
Start price
07.08.23
/
50%
€15.80
Target price
07.08.24
€15.45
Performance (%)
64.56%
Price
24.07.24
€26.20
Summary
This prediction is currently active. The price for Myriad Genetics has massively increased, which is bad news for the SELL prediction by JPMorgan_Chase___Co_. This prediction currently runs until 07.08.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Myriad Genetics | 5.691% | 5.691% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at JPMorgan Chase & Co. from $18.00 to $17.00. They now have an "underweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat